Statement Of Cash Flows [Abstract]

Heidelberg Pharma AG - Filing #6821989

Concept 2020-12-01 to
2021-11-30
2019-12-01 to
2020-11-30
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments to reconcile profit (loss) other than changes in working capital
2.003.116 EUR
1.487.901 EUR
Increase (decrease) in working capital
2.448.279 EUR
998 EUR
Adjustments for decrease (increase) in other assets
10 EUR
0 EUR
Adjustments for increase (decrease) in other liabilities
479 EUR
49 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
803 EUR
734 EUR
Adjustments for undistributed profits of investments accounted for using equity method
13 EUR
71 EUR
Finance costs paid, classified as operating activities
29 EUR
14 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of interests in investments accounted for using equity method
13 EUR
58 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of options
14 EUR
59 EUR
Cash advances and loans from related parties
10.000.000 EUR
0 EUR
Payments for share issue costs
749 EUR
61 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.